This study aimed to provide comprehensive genomic profiling of a clinically definite ALS individual, bearing an intermediate ATXN1 poly-Q expansion and belonging to a large SCA1 family with a “central branch” of SCA1 patients showing early signs and symptoms of lower MN involvement [10]. The gene discussed is ATXN1; the disease is amyotrophic lateral sclerosis.